News & Updates

Low-dose aspirin halves recurrence risk in select CRC patients
Low-dose aspirin halves recurrence risk in select CRC patients
28 Feb 2025 byAudrey Abella

In colorectal cancer (CRC) patients harbouring mutations in the PI3K pathway, adjuvant treatment with aspirin 160 mg daily reduced the recurrence rate by over 50 percent, according to the 3-year results from the ALASCCA trial.

Low-dose aspirin halves recurrence risk in select CRC patients
28 Feb 2025
Prenatal COVID-19 infection, vaccination: Early child developmental concerns allayed
Prenatal COVID-19 infection, vaccination: Early child developmental concerns allayed
25 Feb 2025 byJairia Dela Cruz

Neither SARS-CoV-2 infection exposure nor COVID-19 vaccination during pregnancy poses a significant risk to early child development, as shown in a population-level study said to be the largest to date.

Prenatal COVID-19 infection, vaccination: Early child developmental concerns allayed
25 Feb 2025